RENAISSANCE TECHNOLOGIES LLC

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 1037389 NEW YORK, NY

Position in VRCA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$133,226

-$37,958 QoQ

Shares Held

21,769

-32.7% QoQ

Ownership

0.127%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 43 holders

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. VRCA ranks #265 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$133,226	21,769	-32.7%	Shares	Sole	2026-08-13
2026-03-31	$171,184	32,360	+22.6%	Shares	Sole	2026-05-14
2025-12-31	$219,384	26,400	-9.6%	Shares	Sole	2026-02-12
2025-09-30	$125,813	29,191	-66.5%	Shares	Sole	2025-11-13
2025-06-30	$46,216	87,200	-62.6%	Shares	Sole	2025-08-13
2024-12-31	$163,310	233,300	+57.7%	Shares	Sole	2025-02-13
2024-09-30	$214,547	147,964	+225.0%	Shares	Sole	2024-11-13
2024-06-30	$331,877	45,525	-33.1%	Shares	Sole	2024-08-09
2023-09-30	$264,568	68,100	-57.3%	Shares	Sole	2023-11-14
2023-06-30	$919,161	159,300	+181.9%	Shares	Sole	2023-08-11
2023-03-31	$367,250	56,500	-63.9%	Shares	Sole	2023-05-12
2022-12-31	$430,028	156,374	-32.1%	Shares	Sole	2023-02-13
2022-09-30	$672,476	230,300	+380.8%	Shares	Sole	2022-11-14
2022-06-30	$91,968	47,900	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.